Questionnaire design and the recall of pharmacological treatments: a systematic review
- 30 December 2008
- journal article
- review article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (3) , 175-187
- https://doi.org/10.1002/pds.1703
Abstract
Purpose: We aimed to review systematically the published evidence regarding the effect of questionnaire design on the recall of pharmacological treatments.Methods: The electronic databases Pubmed®, EMBASE™, and Cochrane® Library were searched from inception to October 2007, using the following search terms: drug utilization, pharmaceutical preparations, pharmacoepidemiology, validation studies, methods, epidemiologic methods, interviews, data collection, and questionnaires. Drug utilization studies comparing different types of questionnaire or methods of questionnaire administration were included. Backward and forward citation tracking were also conducted.Results: Eight studies were included in the systematic review, comparing questions asking for specific drugs or indications with open‐ended questions (n = 5), evaluating the use of memory aids (n = 1), or studying the influence of response order on recall (n = 2). The studies were heterogeneous, namely regarding the populations evaluated (e.g., pregnant women, hypertensive patients, general population), mode of questionnaire administration (e.g., personal or telephone interview, self‐administered), recall period (e.g., current use, 1 week, previous episode of a disease), or drugs evaluated (e.g., analgesics, antimalarials, all medicines). Despite the lack of standardization in presentation of results, the prevalence of drug use may vary between 5 and 40% when drug names and indications or pictures are used as memory aids, or as a result of primacy effects in self‐administered questionnaires. The yielding of the questionnaires depended on the pharmacological groups evaluated.Conclusions: Scientific work regarding methods for drug utilization data collection is scarce. The available evidence highlights the importance of knowing the questionnaire characteristics for a proper interpretation of results from drug utilization studies. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 39 references indexed in Scilit:
- Approaches to Assessing the Rationality of Drug Usage in a Developed CountryActa Medica Scandinavica, 2009
- Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database studyBMC Clinical Pharmacology, 2007
- The history of the Drug Utilization Research Group in EuropePharmacoepidemiology and Drug Safety, 2005
- Using a pharmacoepidemiological approach to estimate diabetes type 2 prevalence in PortugalPharmacoepidemiology and Drug Safety, 2005
- Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitorsPharmacoepidemiology and Drug Safety, 2004
- Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjectsClinical Pharmacology & Therapeutics, 2001
- Validation of pharmacy records in drug exposure assessmentPublished by Elsevier ,1997
- Drug utilization studies: a tool for determining the effectiveness of drug use.British Journal of Clinical Pharmacology, 1983
- Utilization of antihypertensive drugs in certain European countriesEuropean Journal of Clinical Pharmacology, 1983
- Recording of drug prescriptions in the county of Jämtland, SwedenEuropean Journal of Clinical Pharmacology, 1977